Article

Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA study

2024-08-13

Abstract excerpt

<title>Abstract</title> <p>Underrepresented populations' participation in clinical trials remains limited, and the potential impact of genomic variants on drug metabolism remains elusive. This study aimed to assess the pharmacokinetics (PK) and pharmacogenomics (PGx) of ribociclib in self-identified Black women with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2) advanced...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e95167cb-a773-5640-b71a-b0b19d1cce6c
DOI: 10.21203/rs.3.rs-4656461/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pharmacokinetics and Pharmacogenomics of Ribociclib in Black Patients with Metastatic Breast Cancer: The LEANORA studyDOI 10.21203/rs.3.rs-4656461/v1Read

Pharmacogenomics in Tailoring First-Line Therapy for Breast Cancer: PharmGKB Database InsightsSemantic proximity Read

The Role of Pharmacogenetic-Based Pharmacokinetic Analysis in Precise Breast Cancer TreatmentSemantic proximity Read

Genomics and pharmacogenomics of breast cancer: current knowledge and trends.Semantic proximity Read

Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.Semantic proximity Read

Cancer pharmacogenomics: implications on ethnic diversity and drug response.Semantic proximity Read

Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.Semantic proximity Read

Pharmacogenomics of third-generation aromatase inhibitors.Semantic proximity Read

The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Semantic proximity Read

Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.Semantic proximity Read

Clinical and Pharmacogenomic Predictors of Survival in Tamoxifen Treated Breast Cancer Female Patients: A Real-World StudySemantic proximity Read

Cancer pharmacogenomics and pharmacoepidemiology: setting a research agenda to accelerate translation.Semantic proximity Read

No Evidence of Genotype‒Treatment Interactions between Endocrine Therapies and Adverse Drug Effects in Women with Breast Cancer: Findings from the UK BiobankSemantic proximity Read